We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aerobox | LSE:ARX | London | Ordinary Share | GB0032654427 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.47 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:6107U AeroBox plc 25 January 2004 26 January 2004 Contact: Jeremy Porter, Seymour Pierce +44 207 107 8000 David Bick, Holborn +44 207 929 5599 Aerobox plc Share placing to fund expansion Strategic Partnership with Kelvin Technologies Inc AeroBox plc has completed a share placing to raise #2.24 million, before expenses, through the issue to investors of 7,000,000 new Ordinary Shares at 32p per share. The net proceeds of the issue will be used to fund working capital and new product development. This follows the announcement made on 21 January that the first sales, subject to contract, of the AeroBox LD3 cargo container had been achieved with Aer Lingus and Virgin Atlantic. The air cargo container industry is worth around US$200m per annum. The first AeroBox product, the LD3 unit, addresses half of that market. AeroBox has also entered into a strategic partnership with Kelvin Technologies Inc to determine the feasibility of producing a refrigerated air cargo container that actively controls product temperature for use by the pharmaceutical, food and related industries. The AeroBox LD3 cargo container is the result of a decade of research and development into composite structure panels. The strength and thermal resistance of these panels enables AeroBox to develop custom made packaging systems for a wide range of applications. Kelvin Technologies is an industry leader in cold chain product management, widely used throughout the pharmaceutical industry. In the market for temperature sensitive products, around 7% wastage occurs due to temperature control difficulties. The World Health Organisation estimates that 50% of all vaccines are lost in transit due to temperature problems. The development of a temperature controlled product would therefore represent a significant new market for AeroBox. Bob Bushman, Chief Executive of AeroBox, commented: "We have increased production capacity by investing in new machinery and moving to new facilities. The partnership with Kelvin Technologies is a timely additional opportunity to broaden our product portfolio and reach new markets." Application will be made for the 7,000,000 new Ordinary Shares issued under the Placing to be admitted to trading on AIM. Dealings are expected to commence on 30 January 2004. - ends - This information is provided by RNS The company news service from the London Stock Exchange END IOEBDGDBBSDGGSU
1 Year Aerobox Chart |
1 Month Aerobox Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions